This result not only provides new insights into the mechanisms explicating the upregulation of VDR in DTC but also suggests that the interaction of VDR with E-cadherin/β-catenin may provide a promising option for facilitating the research of thyroid cancer progression and will help uncover novel clues for the therapeutic strategy of DTC. The gene discussed is CDH1; the disease is thyroid gland carcinoma.